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Abstract
Labor pain and methods of its alleviation constitute the main problem in contemporary
obstetrics,  both  for  the  patients  themselves,  as  well  as  for  the  medical  staff. Concerns
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associated with pain are not meaningless to the course of labor, are inextricably linked to the
quality of perinatal care and to a large extent affect the costs of functioning of the health care
system. Moreover, concerns about labor itself are strongly associated with fear of pain at all.
Most women are aware of pain during labor, but they expect that it should be soothed with
currently  available  methods,  ensuring  safety  for  the  mother  and  the  child.  In  this  paper
pharmacological methods of labor pain relief, including inhaled analgesia, opioid analgesics,
non-opioid drugs, pudendal nerve block and epidural anesthesia were described.
Key words: epidural anesthesia, inhaled analgesia, labor, non-opioid drugs, opioid analgesics,
pain relief, pudendal nerve block.
Labor pain and methods of its alleviation constitute the main problem in contemporary
obstetrics, both for the patients themselves, as well  as for the medical staff [1]. Concerns
associated with pain are not meaningless to the course of labor, are inextricably linked to the
quality of perinatal care and to a large extent affect the costs of functioning of the health care
system. Moreover, concerns about labor itself are strongly associated with fear of pain at all.
[2].  Most women are aware of pain during labor, but they expect that it should be soothed
with currently available methods, ensuring safety for the mother and the child [3].
The essence of inhaled analgesia used during labor is the inhalation of anesthetics in
concentrations ensuring the preservation of full awareness and laryngeal reflex in the patient
[4]. There are many anesthetics that can be administered by inhalation, including: isoflurane,
sevoflurane,  trichlorethylene,  methoxyflurane,  cyclopropane  or  nitrous  oxide.
Trichlorethylene can not be administrated with CO₂ as an absorber because it is flammable
while using of cyclopropane, even at subanesthetic concentrations, is dangerous due to the
risk of explosion. None of these drugs are currently used for analgesia in modern medicine
and they have only historical significance. Also sevoflurane is not used for inhaled analgesia
during labor because it does not analgesic effect in subanesthetic concentrations. However,
subanesthetic concentrations of nitrous oxide, enflurane, isoflurane and methoxyflurane have
no significant effect on uterus contractions and are therefore preferred.
In  modern  obstetric  practice,  only  nitrous  oxide  is  widely  used  for  intrapartum
anesthesia. The reasons  for  this  situation  are  to  be  seen  in  several  of  its  features,  which
include: ease of administration and dosage, non-flammability, lack of acute odor, no effect on
1166
uterus contractions, low toxicity, no  depressive effects onto  the cardiovascular system and
minimal risk of inducing hyperthermia [4-6]. Nitrous oxide was used for the first time during
labor in 1881 by Stanialav Klikovich, who studied the effectiveness of mixture of this gas
with 20% pure oxygen [7], while a device for self-dosing of nitrous oxide was introduced into
obstetric practice by Minnitt in England in 1934 [6]. Currently, nitrous oxide is used in a
mixture with pure oxygen at 1: 1 ratio and can be administered via a mask to the respiratory
system  of  laboring  woman,  from  a  device  that  mixes  both  gases  immediately  before
aspiration, (Nitronox), or as a ready gas mixture in one container, through the mouthpiece
(Entonox). The mouthpiece and the mask have a valve which allows the gas mixture to flow
to the patient only if there is a negative pressure in the mouthpiece or in a well-sealed mask
during inspiration. The dosing valve eliminates the flow of gas when the patient does not
inhale in and limits the exposure of medical personnel to the effect of this medicine. The
Nitronox device  additionally  allows  for the capture of gases exhaled by the patient. This is
important,  because prolonged exposure to nitrous oxide  (especially in the case of medical
personnel) disturbs the metabolism of vitamin B  by converting monovalent cobalt into its₁₂ by converting monovalent cobalt into its
bivalent  form,  which  can  not  serve  as  a  coenzyme  for  the  synthesis  of  methionine  and
methylmalonyl-CoA mutase. Patients  who  chronically  abuse  nitrous  oxide  may  develop
clinical  symptoms  resembling  complex  subacute  spinal  cord  degeneration,  megaloblastic
anemia and increased incidence of spontaneous abortions [8,9]. The mechanism of analgesia
of nitrous oxide results from impulse inhibition in the spinal cord as well as on the supraspinal
level. In addition, it causes the release of endorphins and enkephalins in the central nervous
system [10]. Nitrous  oxide  has  a  weak anesthetic  effect  in  high doses  and analgesic  and
sedative effects in low doses. The efficacy, safety and the risk of adverse reactions depends on
the dose which is a derivative of the drug concentration and the time of exposure [8]. After
the  initial  instruction,  the  laboring  woman  can  use  the  mask  or  mouthpiece  without  any
additional help. This form of analgesia can be used continuously or intermittently - with the
beginning  of  the  moment  of  increasing  the  contraction  force  and  at  the  end,  when  the
contraction  stops. The  maximal  effect  of  analgesic  effect  in  the  case  of  nitrous  oxide  is
reached in about  30-40 seconds after  the start  of  inhalation,  and the disappearance of  its
effects appears after 3-4 exhalations [11]. Intrapartum analgesia with nitrous oxide has no side
effects or threatens the safety of the mother and the fetus. It does not require  intravenous
1167
access  and  continuous  monitoring  of  fetal  well-being,  which  additionally  increases  the
comfort of the woman [8].
The inhaled supply of anesthetic drugs may also in some cases be a supplement to the
parenteral use of opioid analgesics. Nowadays, in most developed countries, parenteral use of
opioid  drugs  is  a  common  practice  for  the  treatment  of  labor  pain  [12]. Parenteral
administration of opioid drugs, apart from regional anesthesia, is the most common method of
pain relief during labor [12]. The most commonly used opioid drug is pethidine produced in
1939 [12]. In  the second half  of the 20th century,  newer opioids,  characterized by better
pharmacokinetic and pharmacodynamic parameters, were introduced for clinical use. Despite
of  this,  perhaps  because  of  the  long-term rooting  in  the  awareness  of  the  medical  staff
working in delivery wards, pethidine is the most-used opioid.  In some parts of the world,
however, this trend is changing in favor of fentanyl, ramifentanil or nalbuphine [13]. Opioid
drugs are often criticized because of their limited analgesic effect and clearly marked side
effects from the mother and the fetus. The most frequently mentioned maternal side effects
are:  weakened  ability  to  make  informed  decisions,  sedation,  hypotension,  nausea  and
vomiting,  urinary  retention,  prolonged  delivery  or  delayed  gastric  emptying  [14,15]. The
delay of intestinal transit significantly increases the risk of aspiration of the gastric contents in
a situation where it is necessary to use general anesthesia. In addition, sedation and the feeling
of drowsiness in the laboring woman makes her reluctant to take a vertical position during
labor, which prolongs its duration and increases the perception of pain [16]. Opioids cross the
placenta easily by a passive diffusion. This is very important that the elimination of the most
commonly used pethidine and its active metabolite norpethidine out of the newborn's body
can last from three up to even six days [17]. Pethidine has a negative impact on the variability
of  the fetal  heart  rate,  it  reduces the number of accelerations  and is  a  risk factor  for  the
occurrence of decelerations in the CTG record [18]. The results of observational studies also
indicate that opioids significantly affect the newborn, which is expressed by the impairment
of the sucking reflex and the reduced alertness of the newborn child. This leads to delay the
effective breastfeeding [19]. Pethidine may be administered by the intramuscular route - then
the single dose ranges from 25-150 mg (0.6-1.2 mg / kg) or intravenously (usually a single
dose  is  50  mg). The  maximum therapeutic  effect  is  achieved  about  30-40  minutes  after
administration of the drug and the next dose, if necessary, is given after 3 to 6 hours. The half-
time of the drug in adults is 3 hours, whereas in neonates it is extended to 23 hours due to the
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immaturity of the enzymatic pathways responsible for the processes of hydrolysis of pethidine
to meperidine acid [20]. Relatively high number of side effects and uncontrolled action after
the intramuscular administration was a contribution to the creation of a new generation of
opioid drugs with a more favorable profile of action [21]. Fentanyl is a synthetic opioid, of
structure similar to that of pethidine,  but with a 50-100 times stronger effect. Due to the
strong lipophilic  properties,  it  penetrates the blood-brain barrier  very quickly,  where after
about 3-5 minutes it reaches a concentration 10-fold higher than in the blood plasma. The
high concentration of fentanyl in the brain is responsible for its rapid elimination and thus
short duration of action. The rapid onset of action and rapid elimination of the drug represent
its  additional  advantage  -  the ease  of  titration  and predictable  profile  of  action,  which is
extremely  useful  in  clinical  practice  [22]. Taking  into  account  the  pharmacokinetics,
pharmacodynamics, greater patient satisfaction, less sedation, shorter duration of labor and
less  difficulty  in  starting  breastfeeding,  fentanyl  seems  to  be  a  much  more  beneficial
alternative to parenteral administration of pethidine [23].
In contrast to centrally acting opioids, non-opioid analgesics act peripherally, directly
at the level of nociceptors of damaged tissues [24]. For this reason, they are referred to as
"peripheral analgesics", which is not exactly the right statement due to the recently discovered
their central mechanism of action. Among non-opioid analgesics, we distinguish three basic
subgroups:  carboxylic  acid  derivatives  (acetylsalicylic  acid  and  non-steroidal  anti-
inflammatory drugs), pyrazolone derivatives (metamizole, phenylbutazone, phenazone) and
aniline derivatives (paracetamol). Drugs from the first two groups have antipyretic and anti-
inflammatory properties in addition to analgesia, while paracetamol has no anti-inflammatory
activity [24]. Non-opioid drugs differ from the opioids with several important features: the
former exhibit the so-called "ceiling effect", which means that there is a maximum dose of the
drug, beyond which the analgesic effect no longer increases,  they do not produce tolerance
and in the case of long-term use they do not lead to addiction. Non-opioid analgesics are used
in many countries as monotherapy to avoid opioid-induced nausea and sedation [25]. The
second significant difference between opioid and non-opioid drugs are  the side effects  of
these latter. While  short-term use of non-opioid drugs in the acute pain is relatively safe, in
the case of chronic use they may damage the mucous membrane of the gastrointestinal tract,
the kidneys or less frequently other  organs [26,27]. Using non-opioid drugs,  an analgesic
effect corresponding to 10 mg of morphine can be achieved. It follows that they are relatively
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weak analgesics and therefore have limited  usefulness  in the treatment of severe and very
severe pain [28].
Pudendal nerve block and cervical blockade are regional anesthetic methods which are
used in obstetrics for decades. The blockage of the pudendal nerve is performed by locally
injecting  of  its  trunk  with  an  anesthetic. As  a  result  area  of  the  perineum,  anal  and  2/3
posterior part of the labia undergo anesthesia. The front part of the labia innervated by the
genito-femoral nerve remains not anaesthetized. This method is used for anesthesia in the
second  stage  of  labor  and  for  vaginal  obstetrical  procedures  [29].  The  blockage  of  the
pudendal nerve can be made through the perineum or vagina, by the administration of 20-25
ml of anesthetic local to the area of the ischial spine. In the common clinical practice, the
most frequently used is vaginal access, which is less painful, has fewer complications and
better efficacy [28].  The cervical blockade involves injecting the local anesthetic, in 2 to 6
punctures to a depth of 3 to 7 millimeters, into the lateral fornices of the vagina.
The needle must be laid parallel to the vaginal part of the uterus arrays [30]. This
treatment affects the conduction of painful stimuli by sensory fibers visceral the lower part of
the uterus, cervix and upper vagina (T10-L1), the so-called bottom hypogastric plexus. Due to
frequent complication in the form of fetal  cardiac arrhythmias including bradycardia,  this
method is not recommended [24].
Nowadays,  the  gold  standard  of  intrapartum  analgesia  is  believed  to  be  lumbar
epidural  anesthesia. The  effectiveness  of  this  kind  of  anesthesia,  in  comparison  to  other
methods, results from the fact that it takes into account the majority of mechanisms of pain
during vaginal delivery. In addition, epidural anesthesia, site of action of which is the spinal
cord  and roots  of  the  spinal  nerves,  gives  the  opportunity  to  eliminate  various  functions
related  to  the  nerve  conduction  and  allows  for  selective  segmental  blocking. Epidural
anesthesia is based on the inhibition of the conductivity in the nerve fibers by blocking the
calcium channels in the cell membrane of the spinal nerve root neurons. The clinical effect is
obtained by administering to the epidural space a solution containing a local anesthetic with
or  without  an opioid drug. The place of  access to  the epidural  space used for  obstetrical
anesthesia is the middle section of the lumbar spine, due to the horizontal course of spinous
processes, the largest width of the epidural space and the location of the spinal cord's core
above the injection site [24]. Among local anesthetics, are used almost exclusively amides
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local  anesthetics:  lignocaine,  prilocaine,  ropivacaine  or  bupivacine. The  clinical  effect  is
achieved after about 10-20 minutes after administration of the drug to the epidural space.
Anesthesia should mainly provide sensory blockade, therefore the use of low concentrations
of local anesthetics should be sought, which ensures the maintenance of the motor function of
the laboring woman. The use of high concentrations of local anesthetics leads to motoric
blockage resulting in a lack of mobility, decreased muscle tone of the pelvic floor and less
effective  pressure  in the second stage of labor. It may result in prolongation of the second
stage of labor and increase of the percentage of surgical deliveries [31, 32]. In addition, large
doses of analgesics may cause sympathetic blockage, which may cause relaxation of vascular
system leading to maternal hypotension, defined as a 20% decrease in blood pressure relative
to baseline [33]. A sudden episode of severe hypotension may lead to a clinically significant
decrease of blood flow in the utero-placental unit, reduced oxygen supply for the fetus , and in
fetuses  with  limited  possibilities  of  compensation,  to  intrauterine  hypoxia  [34]. This  is
prevented  by  intravenous  hydration  of  the  patient  before  administration  of  drugs  to  the
epidural space. The combination of opioids administered epidurally with local  anesthetics
reduces  the  dosage  of  both  drugs,  reduces  the  risk  of  motor  blockage  induced  by  local
analgesia and reduces the risk of side effects from opiates such as urinary retention, pruritus,
chills and fever [35]. The analgesic mixture is administered to the epidural space as a bolus,
either continuously or by means of a patient-controlled infusion pump [36]. The latter two
methods of supplying anesthetic drugs require the placement of a special catheter in the target
space that allows the medication to be administered intermittently or continuously. One of the
varieties of regional anesthesia used to relieve the pain of labor is the combined subarachnoid
- epidural use of opioids, local anesthetics or a mixture of both at the same time. The drugs
are initially administered to the subarachnoidal space and then to the epidural space by a
catheter placed there. Undoubtedly, the advantage of this method is a quick onset and longer
blocking time, but no significant differences in the quality of the anesthesia were observed
[37].
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